Genetic variation of the IL-28B promoter affecting gene expression.
Genetic variation of the IL-28B promoter affecting gene expression.
复制标题
DOI:
10.1371/journal.pone.0026620
复制
发表时间:
2011
期刊:
影响因子:
3.7
通讯作者:
Mizokami M
中科院分区:
文献类型:
--
作者:
Sugiyama M;Tanaka Y;Wakita T;Nakanishi M;Mizokami M
The current standard of care for the treatment of chronic hepatitis C is pegylated interferon-α (PEG-IFNα) and ribavirin (RBV). The treatment achieves a sustained viral clearance in only approximately 50% of patients. Recent whole genome association studies revealed that single nucleotide polymorphisms (SNPs) around IL-28B have been associated with response to the standard therapy and could predict treatment responses at approximately 80%. However, it is not clear which SNP is most informative because the genomic region containing significant SNPs shows strong linkage disequilibrium. We focused on SNPs in close proximity to the IL-28B gene to evaluate the function of each and identify the SNP affecting the IL-28B expression level most. The structures of IL-28A/B from 5′ to 3′-UTR were determined by complete cDNA cloning. Both IL-28A and 28B genes consisted of 6 exons, differing from the CCDS data of NCBI. Two intron SNPs and a nonsynonymous SNP did not affect IL-28B gene function and expression levels but a SNP located in the proximal promoter region influenced gene expression. A (TA) dinucleotide repeat, rs72258881, located in the promoter region was discovered by our functional studies of the proximal SNPs upstream of IL-28B; the transcriptional activity of the promoter increased gradually in a (TA)n length-dependent manner following IFN-α and lipopolysaccharide stimulation. Healthy Japanese donors exhibited a broad range of (TA) dinucleotide repeat numbers from 10 to 18 and the most prevalent genotype was 12/12 (75%), differing from the database (13/13). However, genetic variation of IL-28A corresponding to that of IL-28B was not detected in these Japanese donors. These findings suggest that the dinucleotide repeat could be associated with the transcriptional activity of IL-28B as well as being a marker to improve the prediction of the response to interferon-based hepatitis C virus treatment.
登录
查看更多内容
影响因子:
3.8
作者:
Bartlett, NW;Buttigieg, K;Smith, GL
通讯作者:
Smith, GL
影响因子:
4.4
作者:
Ank, Nina;Iversen, Marie B.;Paludan, Soren R.
通讯作者:
Paludan, Soren R.
影响因子:
158.5
作者:
Ribic, CM;Sargent, DJ;Gallinger, S
通讯作者:
Gallinger, S
影响因子:
29.4
作者:
Rauch, Andri;Kutalik, Zoltan;Bochud, Pierre-Yves
通讯作者:
Bochud, Pierre-Yves
DOI:
10.1073/pnas.95.14.8170
发表时间:
1998-07-07
影响因子:
11.1
作者:
Beutler, E;Gelbart, T;Demina, A
通讯作者:
Demina, A